Suchergebnisse
-
7 Resulte
-
Perry Nisen - Chief Executive Officer and Director - has a PhD in Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Medical Microbiology from Stanford University.Quanta Therapeutics - Biotechnologie - USA
-
Noreen Henig - Director - has a MD Distinction in Immunology from Albert Einstein College of Medicine of Yeshiva University and BA History of Art from Yale University.Avidity Biosciences - Biotechnologie - USA
-
Jeffrey Silber - Chief Medical Officer - has a Doctor of Medicine from Albert Einstein College of Medicine of Yeshiva University and Bachelor of Science in Biology from Harvard University.Vedanta Biosciences - Biotechnologie - USA
-
Theodore Feldman - Chief Medical Officer - hält ein Doctor of Medicine der Albert Einstein College of Medicine of Yeshiva University.Rightway Healthcare - Biotechnologie - USA